ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. - Wikidata - awgldk - TriplyDB

ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

http://www.wikidata.org/entity/Q48491814

about

The compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challenges Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism.Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases.Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis.Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7).Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays Angiotensin-converting enzyme 2: the first decade.Angiotensin II-induced hypertension is modulated by nuclear factor-κBin the paraventricular nucleus.Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling.ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats.Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats.A review of genetic methods and models for analysis of coronavirus-induced severe pneumonitis.Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis Neuroimmune communication in hypertension and obesity: a new therapeutic angle?MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides Regulation of ACE2 in cardiac myocytes and fibroblasts.Angiotensin-converting enzyme 2 and the kidney.Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure Angiotensin converting enzyme 2 in the kidney.Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.Angiotensin-converting enzyme 2 in the brain: properties and future directions.Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart The sweeter side of ACE2: physiological evidence for a role in diabetes.Association of exercise training and angiotensin-converting enzyme 2 activator improves baroreflex sensitivity of spontaneously hypertensive rats New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.Designing heart performance by gene transfer.Cardiovascular protection by angiotensin-converting enzyme 2: a new paradigm.New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism.

P2860

Q26823573-EFB6B200-FF5F-4CEE-AA19-321138CA0CFB Q28081615-782CDE1C-280F-4F9A-921A-3D003051A90D Q33639490-3F74DEFD-11A8-4506-A6AF-6AE619377B11 Q33677369-5F060203-F3E6-47EC-8602-773956EE5836 Q33684855-9EA0574B-5BD6-4F0E-A701-3DA106699372 Q33795353-00988C2D-D5BB-44B8-B2D1-A0FBC80A5316 Q34268946-FCA04286-F892-407D-944B-3698D647D115 Q34423315-00E3025E-3853-46AB-AB20-D021F809CB2F Q34479181-700F204D-EBBA-44AC-AE41-B73E1A9BC19A Q34500735-AD91B680-85B7-4890-B739-CAA51290BB14 Q34510691-2664A086-20DA-470B-847D-7BF9C813D745 Q34799585-54B832A9-D771-4534-89AC-BB7A4FB57BF5 Q34892110-EB559E3E-F0C5-4441-B635-37E0964B2736 Q35217354-BE1E39C9-C204-41F1-817F-1A1A0C9A735F Q35251166-BEFF8907-5783-4F10-BCD5-F7B115E1FB5C Q35543390-4992C0AA-3DE1-4B12-9BBC-352FDBE86372 Q35550937-2D3F074D-A33B-4184-8068-8B1103A7E35E Q35707198-B0E27F57-E6D3-401F-B290-0644D0346D3B Q35726197-D7F38F56-7386-4B25-86F3-AC8B864F3D85 Q35776364-5CF5B90F-7AFE-4796-8E1F-5C95B379A9B1 Q35995112-1A40FCF0-EB7B-48A4-AD3C-8280102EB5C1 Q36033367-2B428B32-D32F-4CC7-8184-F6E1EA77F13E Q36739375-BEF137AB-7984-4BC6-86C5-6C5B1B1EDD88 Q36808001-6E5BFE6F-D197-474A-873A-7E9B340F453B Q36824063-D6FF562E-D106-4E43-9B6E-C119B5733726 Q36977764-AC6DBA10-05DB-40A6-9319-9DEAFBFD7B5E Q37038738-B3A33EB9-BF6A-4B2D-95F7-4EA74376C50B Q37068454-32560BD5-5C69-4420-84FE-A126F893697E Q37081415-3768ECF1-4079-4CCD-B06C-3B47B6F18FA9 Q37097117-D8FD1202-00D3-47A7-944A-FB780587E184 Q37127739-100E61F3-5B8A-4FF3-8B44-D7D926263C4E Q37155907-4C0A4B1A-306B-40A5-BE43-6BA5E02AEEE9 Q37162741-137ACC92-40AE-4D8C-B6B8-6535BFF8879D Q37175696-9EC33B44-E9B9-4A07-963C-7C2BEB0BD1B3 Q37178255-7DA2C39C-1E17-46F0-9944-9C9DA32A45BB Q37183375-F3229022-1872-48AB-9369-9E620E8AAA63 Q37293326-13528B5B-393A-4C50-8D74-BF2B2D17A7DB Q37299072-FB2A1BB4-5008-4993-80F7-7870BCA4B879 Q37608588-CBEA28BD-1418-47C1-93F1-01819DDA6266 Q37660786-D71DA812-76E1-476D-BFEC-2605CF8282D3

P2860

ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

http://www.wikidata.org/entity/Q48491814

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

@en

ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

@nl

type

label

ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

@en

ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

@nl

prefLabel

ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

@en

ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

@nl

P1433

Q48491814-8FDC4F40-C43E-4C2F-A5DE-6CCB5D80D2EA

P1476

Q48491814-F3FC6B75-0046-4C7A-97A7-15C8D5EB704B

P2093

Q48491814-100FF91B-58E9-414B-BC20-7B75D4F49BA9

Q48491814-486181BD-B500-46C4-9549-125016CBC84F

Q48491814-7ED16A93-95A3-42A4-8673-29BC283456F5

Q48491814-9CB36653-C299-45D5-B9D5-3D6889C82E86

Q48491814-A4FA3956-6F91-4638-A541-DC08351B27A5

Q48491814-A9380182-0771-49A5-B96B-088C8F5A79D2

Q48491814-C34376AD-0D1A-4ECE-AA3F-DC63F979C969

Q48491814-CE0FA581-3B90-4382-8812-D9DCD44BAC48

P2860

Q48491814-01BE9549-6D77-4208-AFF7-BCDC9B6DDEEB

Q48491814-040B4054-A356-4B9B-BBAB-FE06663B1F67

Q48491814-2F701BE8-426B-477A-874B-EB81C3084BD7

Q48491814-35E52553-299F-4D54-85B3-46FFE76544B3

Q48491814-50FA93F0-DDF7-4801-8316-915ABECDA026

Q48491814-5E5D531C-36D9-41AB-B40F-C18727527EE0

Q48491814-6CD37F22-9BC6-4DCA-B5E8-7AE8A3FCE960

Q48491814-75192AC8-015A-4544-8643-590877B14EE7

Q48491814-7557B7A1-11CD-47F6-AD12-385BF08004EE

Q48491814-79CF3AC0-BBE1-4F73-B4BA-42E2286574D9

P304

Q48491814-2BEE8030-0CE6-4998-8AD7-26CD7A1FF83D

P31

Q48491814-5BDF0373-7C81-450C-BF65-3993E5988839

P356

Q48491814-6B0B3527-09E8-4190-90B0-C82A35D8DD75

P433

Q48491814-ECBC8816-9399-41A7-8554-4492BD261B76

P478

Q48491814-C268003C-C0F8-4FCF-93E6-782F74D74EEF

P577

Q48491814-D5431195-8B05-4E29-B88C-0B778ED71DAA

P5875

Q48491814-F50420FF-F0F2-453A-A575-359AF5C98DA8

P698

Q48491814-F3F7787D-9427-426F-AD0B-867BB4DF2411

P921

Q48491814-ECDE5A0D-EF49-45D3-BAB2-234DBDA3D1DF

P356

PHYSIOLGENOMICS.00312.2005

P1433

Physiological Genomics

P1476

ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

@en

P2093

Carlos Díez-Freire

http://www.w3.org/2001/XMLSchema#string

Jorge Vázquez

http://www.w3.org/2001/XMLSchema#string

Lihui Yuan

http://www.w3.org/2001/XMLSchema#string

María F Correa de Adjounian

http://www.w3.org/2001/XMLSchema#string

Merari F R Ferrari

http://www.w3.org/2001/XMLSchema#string

Mohan K Raizada

http://www.w3.org/2001/XMLSchema#string

Raquel Torres

http://www.w3.org/2001/XMLSchema#string

Xeve Silver

http://www.w3.org/2001/XMLSchema#string

P2860

Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins

ACE2 gene expression is up-regulated in the human failing heart

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function

Lessons from rat models of hypertension: from Goldblatt to genetic engineering

Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension

Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation.

Novel peptide inhibitors of angiotensin-converting enzyme 2.

Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology.

The role of ACE2 in cardiovascular physiology.

P304

12-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/PHYSIOLGENOMICS.00312.2005

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6996225

http://www.w3.org/2001/XMLSchema#string

P698

16788004

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology